Images

Sources

Experiment + Assay

Phenotypes

Human Diseases

fig.7.a

Mimoto MS et al. (2015)

Xla Wt + dndvl2-GFP

NF35/36 (in situ hybridization)

Expression Phenotype
decreased amount tal1.S expression in posterior ventral blood island

fig.7.c

Mimoto MS et al. (2015)

Xla Wt + dndvl2-GFP

NF35/36 (in situ hybridization)

Expression Phenotype
decreased amount hba3.L expression in posterior ventral blood island

fig.S1.j

Mamidi A et al. (2012)

Xla Wt + dvl2 MO + dvl3 MO

NF10.5 (in situ hybridization)

Expression Phenotype
decreased amount szl.L expression in marginal zone

fig.1.d

Mamidi A et al. (2012)

Xla Wt + dndvl2

NF10.5 (in situ hybridization)

Expression Phenotype
decreased amount tbxt.S expression in marginal zone

fig 6.e

Li Y et al. (2008)

Xla Wt + dndvl2-GFP + sfrp5 MO

NF18 (in situ hybridization)

Expression Phenotype
decreased amount hhex.L expression in foregut endoderm

fig 6.e

Li Y et al. (2008)

Xla Wt + dndvl2-GFP + sfrp5 MO

NF35/36 (in situ hybridization)

Expression Phenotype
decreased amount nr1h5.L expression in liver